<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">763496</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2021.763496</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Diagnostic Value of Immune-Related Genes in Kawasaki Disease</article-title>
<alt-title alt-title-type="left-running-head">Liu et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Immune Genes in Kawasaki Disease</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Dong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1446677/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Meixuan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jing</surname>
<given-names>Fengchuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yi</surname>
<given-names>Qijian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Department of Cardiovascular Medicine, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children&#x2019;s Hospital of Chongqing Medical University, <addr-line>Chongqing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Department of Pediatrics, Sichuan Clinical Research Center for Birth Defects, The Affliated Hospital of Southwest Medical University, <addr-line>Luzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Chongqing Key Laboratory of Pediatrics, <addr-line>Chongqing</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Department of Gastrointestinal Surgery, The Affliated Hospital of Southwest Medical University, <addr-line>Luzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/394191/overview">Lam Cheung Tsoi</ext-link>, University of Michigan, United&#x20;States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1474710/overview">Lv Haitao</ext-link>, Children&#x2019;s Hospital of Soochow University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/679740/overview">Kenichi Shimada</ext-link>, Cedars Sinai Medical Center, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/768532/overview">Lijian Xie</ext-link>, Shanghai Children&#x2019;s Hospital, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Qijian Yi, <email>qjyi2003@aliyun.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Applied Genetic Epidemiology, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>763496</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Liu, Song, Jing, Liu and Yi.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Liu, Song, Jing, Liu and Yi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Kawasaki disease (KD) is a systemic vasculitis that predominantly damages medium- and small-sized vessels, and mainly causes coronary artery lesions (CALs). The diagnostic criterion of KD mainly depends on clinical features, so children could be easily misdiagnosed and could suffer from CALs. Through analysis, a total of 14&#x20;immune-related DEGs were obtained, of which <italic>IL1B</italic>, <italic>ADM</italic>, <italic>PDGFC</italic>, and <italic>TGFA</italic> were identified as diagnostic markers of KD. Compared with the non-KD group, KD patients contained a higher proportion of naive B&#x20;cells, activated memory CD4 T&#x20;cells, gamma delta T&#x20;cells, and neutrophils, while the proportions of memory B&#x20;cells, CD8 T&#x20;cells, activated memory CD4 T&#x20;cells, and activated NK cells were relatively lower. In conclusion, immune-related genes can be used as diagnostic markers of KD, and the difference in immune cells between KD and non-KD might provide new insight into understanding the pathogenesis of&#x20;KD.</p>
</abstract>
<kwd-group>
<kwd>Kawasaki disease</kwd>
<kwd>immune-related genes</kwd>
<kwd>immune cells</kwd>
<kwd>diagnostic</kwd>
<kwd>CIBERSORTx</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Kawasaki disease (KD) is a systemic vasculitis that predominantly damages medium- and small-sized vessels, and mainly causes coronary artery lesions (CALs). KD has become the main cause of acquired heart disease in children; 80% of these cases occur in children aged 6&#xa0;months to 5&#xa0;years (<xref ref-type="bibr" rid="B30">Makino et&#x20;al., 2015</xref>), and timely diagnosis and treatment with intravenous immunoglobulin (IVIG) have reduced CALs by about 84% (<xref ref-type="bibr" rid="B31">McCrindle et&#x20;al., 2017</xref>). However, some patients, especially infants under 6&#x20;months of age and adolescents, did not meet the criterion of KD, called &#x201c;incomplete KD&#x201d;, and it is difficult to make a diagnosis in the early stage of the disease. If there is a special index for KD, the early diagnosis will be easy. On the other hand, delayed diagnosis or missed diagnosis may also cause excessive drug treatment or invasive procedures in KD children. Therefore, an efficient diagnostic index of KD is pursued.</p>
<p>Diagnosis guidelines of KD provided by AHA and the Japanese Ministry of Health are mainly based on clinical symptoms and signs (<xref ref-type="bibr" rid="B2">Ayusawa et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B31">McCrindle et&#x20;al., 2017</xref>). Some laboratory data, such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), albumin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) level, thrombocytosis, leukocytosis, raised transaminases, hyponatremia, and pyuria, may be helpful in the diagnosis of KD (<xref ref-type="bibr" rid="B12">Cho et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B29">Lin et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B36">Reddy et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B15">Dionne et&#x20;al., 2017</xref>), but all of them are yet to find the same change in other immune and infectious disease, and cannot act as special diagnostic indexes for&#x20;KD.</p>
<p>The pathogenesis of KD have not been clear so far. However, studies have demonstrated that both immune cells and immune-related genes are involved in the pathogenesis of KD (<xref ref-type="bibr" rid="B39">S&#xe1;nchez-Manubens et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B38">Sakurai et&#x20;al., 2019</xref>). Evaluating the difference of immune cell composition in KD from the perspective of the immune system may have great value in elucidating the molecular mechanism and developing new diagnostic algorithms of KD. Bioinformatics has now been widely used in revealing the molecular mechanism of diseases. CIBERSORTx is an analysis tool to infer the expression of immune cells and obtain various immune cell proportions from samples based on gene expression or sequencing data (<xref ref-type="bibr" rid="B32">Newman et&#x20;al., 2019</xref>).</p>
<p>In this study, we downloaded the microarray datasets of KD from Gene Expression Omnibus (GEO) database and performed differential expression immune-related gene analysis; least absolute shrinkage and selection operator (Lasso) regression algorithm and support vector machine-recursive feature elimination (SVM-RFE) algorithm were used to further screen the diagnostic markers of KD. Based on the diagnostic markers, we have developed and verified a diagnostic model. Subsequently, CIBERSORTx was used to assess the relative content of 22 kinds of immune cell subsets in whole blood in children with KD. In addition, the relationship between diagnostic markers and immune cells was analyzed to better understand the molecular immune mechanism of&#x20;KD.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Microarray Data</title>
<p>The raw data of gene chip of GSE73461, GSE68004, GSE18606, GSE73463, and GSE63881 were downloaded from the GEO (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>) database. GSE73461 contains 459 samples (all children &#x3c;17&#xa0;years of age), including acute KD (<italic>n</italic>&#x20;&#x3d; 78), healthy (<italic>n</italic>&#x20;&#x3d; 55), bacterial infection (<italic>n</italic>&#x20;&#x3d; 52), viral infection (<italic>n</italic>&#x20;&#x3d; 94), juvenile idiopathic arthritis (<italic>n</italic>&#x20;&#x3d; 66), Henoch-Sch&#xf6;nlein purpura (<italic>n</italic>&#x20;&#x3d; 18), and infections of uncertain bacterial or viral etiology (<italic>n</italic>&#x20;&#x3d; 96). GSE68004 contains 162 samples, and its raw data were divided into two parts, part 1 including acute KD (<italic>n</italic>&#x20;&#x3d; 62), healthy (<italic>n</italic>&#x20;&#x3d; 14), adenovirus (<italic>n</italic>&#x20;&#x3d; 9), and group A <italic>streptococcus</italic> (<italic>n</italic>&#x20;&#x3d; 16), and part 2 including acute KD (<italic>n</italic>&#x20;&#x3d; 27), healthy (<italic>n</italic>&#x20;&#x3d; 23), adenovirus (<italic>n</italic>&#x20;&#x3d; 10), and group A <italic>streptococcus</italic> (<italic>n</italic>&#x20;&#x3d; 1). GSE18606 contains 48 samples, including acute KD (<italic>n</italic>&#x20;&#x3d; 20) and healthy (<italic>n</italic>&#x20;&#x3d; 9). GSE73463 contains 233 samples, namely, acute KD (<italic>n</italic>&#x20;&#x3d; 146) and convalescent KD (<italic>n</italic>&#x20;&#x3d; 87). GSE63881 contains 341 samples, namely, acute KD (<italic>n</italic>&#x20;&#x3d; 171) and convalescent KD (<italic>n</italic>&#x20;&#x3d; 170). The GSE73461 was used as the training set; GSE68004, GSE18606, GSE73463, and GSE63881 were used as the independent validation&#x20;set.</p>
</sec>
<sec id="s2-2">
<title>Data Preprocessing and Identification of Differentially Expressed Genes (DEGs)</title>
<p>Data analysis used R software (version 4.0.2, <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>) and bioconductor packages (<ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org/">http://www.bioconductor.org/</ext-link>). Raw data of GSE73461, GSE68004, GSE18606, GSE73463, and GSE63881 datasets were read, background correction and data normalization through the &#x201c;limma&#x201d; package (<ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org/packages/release/bioc/html/limma.html">http://www.bioconductor.org/packages/release/bioc/html/limma.html</ext-link>). Considering the possibility of information loss during the removing batch difference processing, the datasets have not been merged. Linear models of &#x201c;limma&#x201d; package was used to screen DEGs of GSE73461 by comparing the expression values between KD and non-KD, and &#x7c;log2FC&#x7c; &#x3e; 1 and adjusted <italic>p</italic>&#x20;&#x3c; 0.01 were considered statistically significant. The pheatmap (<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/">https://bioconductor.org/packages/release/bioc/html/</ext-link> heatmaps. html) and ggplot2 (<ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggplot2/index.html">https://cran.r-project.org/web/packages/ggplot2/index.html</ext-link>) packages were used to draw a heatmap and volcano map to show the differential expression of&#x20;DEGs.</p>
<p>Immune-related genes were downloaded from the Immunology Database and Analysis Portal database (ImmPort, <ext-link ext-link-type="uri" xlink:href="https://www.immport.org/shared/genelists">https://www.immport.org/shared/genelists</ext-link>), in which 1,509 genes contain 17 immune categories based on molecular function (<xref ref-type="bibr" rid="B4">Bhattacharya S et&#x20;al., 2014</xref>). The immune-related DEGs were obtained by the DEGs and immune-related genes were overlapped.</p>
</sec>
<sec id="s2-3">
<title>Functional Analysis of Immune-Related Differentially Expressed Genes</title>
<p>To assess the potential biologic functions of immune-related DEGs, Disease Ontology (DO), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were performed by the &#x201c;clusterProfiler&#x201d; package (<xref ref-type="bibr" rid="B49">Yu G et&#x20;al., 2012</xref>), respectively. Gene set enrichment analysis (GSEA) was performed on the all immune-related genes expression matrix by the &#x201c;clusterProfiler&#x201d; package. <italic>p</italic>&#x20;&#x3c; 0.05 was considered statistically significant.</p>
</sec>
<sec id="s2-4">
<title>Screening and Verification of Diagnostic Markers</title>
<p>Based on immune-related DEGs, candidate diagnostic markers for KD were selected through integrated analysis of two algorithms including Lasso logistic regression (<xref ref-type="bibr" rid="B42">Tibshirani R et&#x20;al., 1996</xref>) with penalty conducted by 10-fold cross-validation and SVM-RFE (<xref ref-type="bibr" rid="B22">Huang M et&#x20;al., 2014</xref>). A logistic regression model was used to construct a diagnostic signature based on the candidate immune-related genes. Expression matrices of the GSE68004, GSE18606, GSE73463, and GSE63881 were used as independent datasets to verify each candidate gene and the diagnostic model. Receiver operating characteristic (ROC) curves were used to evaluate the accuracy and efficiency of the candidate genes and the diagnostic&#x20;model.</p>
</sec>
<sec id="s2-5">
<title>Evaluation of Immune Cell Level</title>
<p>CIBERSORTx (<xref ref-type="bibr" rid="B32">Newman AM et&#x20;al., 2019</xref>) algorithm was used to quantify the proportions of immune cells in the samples of GSE73461. This algorithm contains 22 kinds of immune cells. Barplot and violin diagrams were drawn to visualize the differences of immune cell in different diagnostic samples; correlation heatmap was drawn to visualize the correlation of immune&#x20;cells.</p>
</sec>
<sec id="s2-6">
<title>Correlation Analysis Between Diagnostic Markers and Immune Cells</title>
<p>Spearman correlation analysis on diagnostic markers and immune cells was performed, and the analysis results were visualized.</p>
</sec>
<sec id="s2-7">
<title>Statistical Analysis</title>
<p>Statistical analyses were completed using the SPSS 22.0 software for Windows (SPSS, Chicago). All values are shown as mean&#x20;&#xb1; standard deviation, or number and percentage (<italic>n</italic>, %). To compare the differences between groups, Student&#x2019;s <italic>t</italic>-tests were used for Continuity variables. Chi-square test was used to compare frequencies between groups. A two-tailed <italic>p</italic> value &#x3c; 0.05 was used as a threshold for determining statistical significance.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Demographic Features and Differentially Expressed Genes Screening in the Training Set</title>
<p>The numbers of children in each diagnostic category and demographic features are summarized in <xref ref-type="table" rid="T1">Table&#x20;1</xref>. A total of 100 DEGs were identified between 78 KD and 381&#x20;non-KD samples in the training set with the cutoff criteria of &#x7c;log<sub>2</sub>FC&#x7c; &#x3e; 1 and adjusted <italic>p</italic>&#x20;&#x3c; 0.01. Fourteen immune-related DEGs were obtained by intersections with immune-related genes, as shown in the volcano plot and heatmap (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>). All the screened genes were upregulated.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Demographic features of each dataset.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Dataset</th>
<th rowspan="2" align="center">Diagnosis</th>
<th colspan="3" align="center">Age (years)</th>
<th colspan="4" align="center">Gender</th>
</tr>
<tr>
<th align="center">Age</th>
<th align="center">
<italic>F</italic>
</th>
<th align="center">
<italic>p</italic>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</th>
<th align="center">Male</th>
<th align="center">Female</th>
<th align="center">
<italic>&#x3c7;</italic>
<sup>
<italic>2</italic>
</sup>
</th>
<th align="center">
<italic>p</italic>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="7" align="left">GSE73461</td>
<td align="left">KD</td>
<td align="center">&#x3c;17</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">43 (9.37%)</td>
<td align="char" char="(">35 (7.63%)</td>
<td align="char" char=".">0.016</td>
<td align="char" char=".">0.900</td>
</tr>
<tr>
<td align="left">Bacterial infection</td>
<td align="center">&#x3c;17</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">22 (4.79%)</td>
<td align="char" char="(">30 (6.54)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">Viral infection</td>
<td align="center">&#x3c;17</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">66 (14.38%)</td>
<td align="char" char="(">28 (6.10%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">Juvenile idiopathic arthritis (JIA)</td>
<td align="center">&#x3c;17</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">25 (5.45%)</td>
<td align="char" char="(">41 (8.93%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">Henoch-Sch&#xf6;nlein purpura (HSP)</td>
<td align="center">&#x3c;17</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">9 (1.96%)</td>
<td align="char" char="(">9 (1.96%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">Uncertain</td>
<td align="center">&#x3c;17</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">62 (13.51%)</td>
<td align="char" char="(">34 (7.41%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">Healthy</td>
<td align="center">&#x3c;17</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">29 (6.32%)</td>
<td align="char" char="(">26 (5.66%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="5" align="left">GSE68004</td>
<td align="left">Complete KD</td>
<td align="char" char=".">3.68&#x20;&#xb1; 2.50</td>
<td align="char" char=".">15.889</td>
<td align="char" char=".">&#x3c;0.001</td>
<td align="char" char="(">32 (19.75%)</td>
<td align="char" char="(">44 (27.16%)</td>
<td align="char" char=".">0.103</td>
<td align="char" char=".">0.748</td>
</tr>
<tr>
<td align="left">Incomplete KD</td>
<td align="char" char=".">4.65&#x20;&#xb1; 3.52</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">9 (5.56%)</td>
<td align="char" char="(">4 (2.47)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">Adenovirus (HAdV)</td>
<td align="char" char=".">4.14&#x20;&#xb1; 2.48</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">10 (6.17%)</td>
<td align="char" char="(">9 (5.56%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">Group A streptococcal disease (GAS)</td>
<td align="char" char=".">5.46&#x20;&#xb1; 4.12</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">10 (6.17%)</td>
<td align="char" char="(">7 (4.32%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">Healthy</td>
<td align="char" char=".">7.14&#x20;&#xb1; 4.62</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">15 (9.26%)</td>
<td align="char" char="(">22 (13.58%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="2" align="left">GSE18606</td>
<td align="left">KD</td>
<td align="char" char=".">2.98&#x20;&#xb1; 2.13</td>
<td align="char" char=".">1.121</td>
<td align="char" char=".">0.299</td>
<td align="char" char="(">10 (34.48%)</td>
<td align="char" char="(">10 (34.48%)</td>
<td align="char" char=".">0.697</td>
<td align="char" char=".">0.404</td>
</tr>
<tr>
<td align="left">Healthy</td>
<td align="char" char=".">2.11&#x20;&#xb1; 1.46</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">3 (10.34%)</td>
<td align="char" char="(">6 (20.69%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="2" align="left">GSE73463</td>
<td align="left">Acute KD</td>
<td align="center">&#x3c;17</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">60 (25.75%)</td>
<td align="char" char="(">86 (36.91%)</td>
<td align="char" char=".">0.684</td>
<td align="char" char=".">0.408</td>
</tr>
<tr>
<td align="left">Convalescent KD</td>
<td align="center">&#x3c;17</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">31 (13.30%)</td>
<td align="char" char="(">56 (24.03%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="2" align="left">GSE63881</td>
<td align="left">Acute KD</td>
<td align="char" char=".">3.32&#x20;&#xb1; 2.83</td>
<td align="char" char=".">0.001</td>
<td align="char" char=".">0.975</td>
<td align="char" char="(">69 (20.23%)</td>
<td align="char" char="(">102 (29.91%)</td>
<td align="char" char=".">0.002</td>
<td align="char" char=".">0.964</td>
</tr>
<tr>
<td align="left">Convalescent KD</td>
<td align="char" char=".">3.32&#x20;&#xb1; 2.84</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="char" char="(">69 (20.23%)</td>
<td align="char" char="(">101 (29.62%)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>Comparison between the KD group and the non-KD group, or between the acute KD group and the convalescent KD&#x20;group.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Immune-related DEGs expression volcano plot and heatmap between KD and non-KD. <bold>(A)</bold> Volcano plot of immune-related DEGs; red represents upregulated differential genes, and black represents no significant difference genes (&#x7c;log2FC&#x7c; &#x3e; 1 and adjusted <italic>p</italic>&#x20;&#x3c; 0.01). <bold>(B)</bold> Heatmap of immune-related DEGs in KD and non-KD. From blue to red represents the change from low expression to high expression (all immune-related DEGs).</p>
</caption>
<graphic xlink:href="fgene-12-763496-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Functional Correlation Analysis of Immune-Related Differentially Expressed Genes</title>
<p>DO enrichment analysis showed that the immune-related DEGs were mainly involved atherosclerosis, arteriosclerotic cardiovascular disease, arteriosclerosis, endocrine system disease, polycystic ovary syndrome, lymphadenitis, lymph node disease, lymphatic system disease, periodontitis, and Kawasaki disease (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). GO analysis revealed that mainly functional categories in the biological processes (BP) involved regulation of inflammatory response, positive regulation of cell division, regulation of cell division, female pregnancy, regulation of cytokine secretion, multi-multicellular organism process, cytokine secretion, regulation of peptidyl-tyrosine phosphorylation, neuroinflammatory response, and positive regulation of hormone biosynthetic process; for molecular function (MF), the main terms involved receptor ligand activity, signaling receptor activator activity, growth factor receptor binding, cytokine activity, cytokine receptor activity, immune receptor activity, growth factor activity, cytokine receptor binding, interleukin-1 receptor binding, and hormone activity; for cellular components (CC), no term was enriched at the same cutoff criteria of BP and MF (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>). KEGG pathway analysis revealed that the immune-related DEGs mainly involved cytokine&#x2013;cytokine receptor interaction, prostate cancer, TNF signaling pathway, MAPK signaling pathway, fluid shear stress and atherosclerosis, and inflammatory bowel disease (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>). GSEA analysis showed that the enriched pathways mainly involved TNF signaling pathway, prostate cancer, necroptosis, fluid shear stress and atherosclerosis, estrogen signaling pathway, IL-17 signaling pathway, NOD-like receptor signaling pathway, neuroactive ligand&#x2013;receptor interaction, osteoclast differentiation, and Toll-like receptor signaling pathway (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Disease Ontology (DO), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of immune-related DEGs. <bold>(A)</bold> DO enrichment analysis (top 10 according to adjusted <italic>p</italic> value). <bold>(B)</bold> GO enrichment analysis; the figure represents biological process and molecular function (top 10 according to adjusted <italic>p</italic> value, respectively). <bold>(C)</bold> KEGG pathway analysis results of immune-related DEGs.</p>
</caption>
<graphic xlink:href="fgene-12-763496-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Gene set enrichment analysis (GSEA) of all immune-related genes in the training set (top five according to normalized enrichment score).</p>
</caption>
<graphic xlink:href="fgene-12-763496-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Screening and Verification of Diagnostic Markers</title>
<p>Four genes were identified from immune-related DEGs by using the Lasso algorithm (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>), and twelve genes were selected by using the SVM-RFE algorithm (<xref ref-type="fig" rid="F4">Figure&#x20;4C</xref>). After overlapping the gene markers obtained by the two algorithms, four candidate diagnosis-related genes were obtained (<xref ref-type="fig" rid="F4">Figure&#x20;4D</xref>). In order to further test the diagnostic efficacy of the four candidate genes, a logistic regression model was established (<xref ref-type="table" rid="T2">Table&#x20;2</xref>), and validation was performed through the GSE68004, GSE18606, GSE73463, and GSE63881 datasets. The area under the curve (AUC) of ROC for the logistic regression model was 0.882 in the training set (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>), and reached a high level in all validation sets (<xref ref-type="fig" rid="F5">Figures 5B&#x2013;F</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Two algorithms were used for diagnostic markers for selection. <bold>(A)</bold> Least absolute shrinkage and selection operator (Lasso) algorithm to screen diagnostic markers, 10-fold cross-validation for selection in the Lasso model. Different colors represent different genes. <bold>(B)</bold> Lasso coefficient profiles of 14&#x20;immune-related DEGs. <bold>(C)</bold> The accuracy of the estimate generation for the support vector machine-recursive feature elimination (SVM-RFE) algorithm. <bold>(D)</bold> The individual feature selection by Lasso and SVM-RFE algorithms and the intersection of diagnostic markers obtained by the two algorithms.</p>
</caption>
<graphic xlink:href="fgene-12-763496-g004.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Diagnostic markers for KD.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Intercept and genes</th>
<th align="center">
<italic>&#x3b2;</italic>
</th>
<th align="center">Odds ratio (95% CI)</th>
<th align="center">
<italic>p</italic>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Intercept</td>
<td align="char" char=".">&#x2212;23.5334</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="left">
<italic>IL1B</italic>
</td>
<td align="char" char=".">0.7655</td>
<td align="char" char="(">2.150 (1.192&#x2013;4.019)</td>
<td align="char" char=".">0.013</td>
</tr>
<tr>
<td align="left">
<italic>ADM</italic>
</td>
<td align="char" char=".">0.6158</td>
<td align="char" char="(">1.851 (0.785&#x2013;4.555)</td>
<td align="char" char=".">0.169</td>
</tr>
<tr>
<td align="left">
<italic>PDGFC</italic>
</td>
<td align="char" char=".">0.7697</td>
<td align="char" char="(">2.159 (1.503&#x2013;3.161)</td>
<td align="char" char=".">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">
<italic>TGFA</italic>
</td>
<td align="char" char=".">0.2468</td>
<td align="char" char="(">1.280 (0.736&#x2013;2.238)</td>
<td align="char" char=".">0.383</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>ROC curve of the predictive efficacy verification of the single diagnostic marker and 4-gene diagnostic model. <bold>(A)</bold> ROC curve of training set. <bold>(B&#x2013;D)</bold> ROC curve of verification sets, each dataset contains acute KD and non-KD samples. <bold>(E,F)</bold> ROC curve of verification sets, each dataset contains acute KD and convalescent KD samples.</p>
</caption>
<graphic xlink:href="fgene-12-763496-g005.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Immune Cell Analyses Results</title>
<p>Using CIBERSORTx algorithm, we first investigated the differences of 22 immune cell subsets between KD and non-KD whole blood samples; results from different diagnostic classifications were averaged (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>). The correlation plot of 18 immune cells (4 types of immune cells had an estimated abundance of 0) in training set KD samples showed that CD8 T&#x20;cells had a significant low positive correlation with resting NK cells (<italic>r</italic>&#x20;&#x3d; 0.426, <italic>p</italic>&#x20;&#x3d; 0.001), a significant low negative correlation with macrophages M0 (<italic>r</italic>&#x20;&#x3d; &#x2212;0.378, <italic>p</italic>&#x20;&#x3c; 0.001), and a significant moderate negative correlation with monocytes, activated dendritic cells, and neutrophils (<italic>r</italic>&#x20;&#x3d; &#x2212;0.561, &#x2212;0.591, and &#x2212;0.624; all <italic>p</italic>&#x20;&#x3c; 0.001). Regulatory T&#x20;cells (Tregs) had a significant low negative correlation with monocytes (<italic>r</italic>&#x20;&#x3d; &#x2212;0.318, <italic>p</italic>&#x20;&#x3d; 0.003). Resting NK cells had a low negative correlation with monocytes and activated dendritic cells (<italic>r</italic>&#x20;&#x3d; &#x2212;0.462 and &#x2212;0.432, <italic>p</italic>&#x20;&#x3d; 0.008 and &#x3c;0.001). Activated dendritic cells had a low positive correlation with monocytes and resting mast cells (<italic>r</italic>&#x20;&#x3d; &#x2212;0.309 and 0.386, <italic>p</italic>&#x20;&#x3d; 0.042 and &#x3c;0.001) (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>). Compared with non-KD, whole blood of KD patients contained a higher proportion of na&#xef;ve B&#x20;cells, activated memory CD4 T&#x20;cells, gamma delta T&#x20;cells, monocytes, M0 macrophages, activated dendritic cells, activated mast cells, and neutrophils, while the proportions of memory B&#x20;cells, CD8 T&#x20;cells, activated memory CD4 T&#x20;cells, activated NK cells, M1 and M2 macrophages, and resting mast cells were relatively lower (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Evaluation and visualization of immune cell analyses. <bold>(A)</bold> Relative percentage of 22 immune cell subpopulations in 459 samples from GSE73461 dataset, results from different diagnostic classifications were averaged. <bold>(B)</bold> Correlation plot of 18 immune cells (4 types of immune cells had an estimated abundance of 0) in 78 KD samples from GSE73461. The size of the colored dots represents the strength of the correlation; blue indicates the positive correlation, and red indicates the negative correlation; the larger the dots and the darker the color, the stronger the correlation. <bold>(C)</bold> The difference of 20 types of immune cells between KD and non-KD (2 types of immune cells had an estimated abundance of 0); blue represents non-KD, and red represents KD; <italic>p</italic>&#x20;&#x3c; 0.05 was considered statistically significant.</p>
</caption>
<graphic xlink:href="fgene-12-763496-g006.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Correlation Analysis Between Diagnostic Markers and Immune Cells in Kawasaki Disease</title>
<p>Correlation analysis showed that <italic>IL1B</italic> was positively correlated with neutrophils, activated mast cells, and M0 macrophages, and negatively correlated with CD8 T&#x20;cells, resting mast cells, activated NK cells, and naive CD4 T&#x20;cells (<xref ref-type="fig" rid="F7">Figure&#x20;7A</xref>). <italic>ADM</italic> was positively correlated with neutrophils, gamma delta T&#x20;cells, M0 macrophages, monocytes, and activated mast cells, and negatively correlated with CD8 T&#x20;cells, resting NK cells, and na&#xef;ve CD4 T&#x20;cells (<xref ref-type="fig" rid="F7">Figure&#x20;7B</xref>). <italic>PDGFC</italic> was positively correlated with monocytes, gamma delta T&#x20;cells, activated dendritic cells, M0 macrophages, and neutrophils, and negatively correlated with CD8 T&#x20;cells, resting NK cells, and regulatory T&#x20;cells (Tregs) (<xref ref-type="fig" rid="F7">Figure&#x20;7C</xref>). <italic>TGFA</italic> was positively correlated with neutrophils, gamma delta T&#x20;cells, M0 macrophages, and monocytes, and negatively correlated with CD8 T&#x20;cells, regulatory T&#x20;cells (Tregs), naive CD4 T&#x20;cells, and resting NK cells (<xref ref-type="fig" rid="F7">Figure&#x20;7D</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Spearman correlation analysis between diagnostic markers and immune cells in KD. <bold>(A)</bold> Correlation between IL1B and immune cells. <bold>(B)</bold> Correlation between ADM and immune cells. <bold>(C)</bold> Correlation between PDGFC and immune cells. <bold>(D)</bold> Correlation between TGFA and immune cells. The size and color of the dots represents the <italic>p</italic>-value and the strength of the correlation between diagnostic markers and immune cells; red represents the positive correlation, and blue represents the negative correlation. The larger the dots, the lower the <italic>p</italic>-value, and the bluer or redder, the stronger the correlation. <italic>p</italic>&#x20;&#x3c; 0.05 was considered statistically significant.</p>
</caption>
<graphic xlink:href="fgene-12-763496-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The diagnostic criterion of KD mainly depends on clinical symptoms and signs, but some patients, especially infants under 6&#x20;months old and adolescents, did not meet the criterion in the early stage of disease, and thus it is difficult to make a timely diagnosis. Delayed diagnosis and treatment may cause serious adverse outcomes such as CAAs. Abnormal gene expression level has been studied in diagnosis of KD (<xref ref-type="bibr" rid="B26">Kuo et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B23">Jaggi et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B46">Wright et&#x20;al., 2018</xref>). However, these studies proposed that biomarkers were too many or not further validated by the external cohort. In this study, we developed a simple and concise diagnosis model, composed of four genes, by analyzing expression levels of immune-related genes. Verification of this model was performed by three other external datasets including KD and non-KD, and shows a great capacity for diagnosis of KD. At the same time, this model was validated with two datasets including acute KD and convalescent&#x20;KD.</p>
<p>The training set was used to identify 14&#x20;immune-related DEGs. DO enrichment analysis showed that the DEGs were mainly related to KD, atherosclerosis, arteriosclerosis, and arteriosclerotic cardiovascular disease. This enrichment result is consistent with previous studies that have shown an increased risk of early atherosclerosis in children with KD (<xref ref-type="bibr" rid="B11">Cho et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B50">Zhang et&#x20;al., 2016</xref>). In addition, both KEGG and GSEA were enriched in fluid shear stress and atherosclerosis, and tumor necrosis factor (TNF) signaling pathway. <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/?size=100&amp;term=Shimizu+M&amp;cauthor_id=29625336">Masaki</ext-link> et&#x20;al. (<xref ref-type="bibr" rid="B47">Xie et&#x20;al., 2018</xref>). revealed that gene polymorphisms of TNF may affect KD susceptibility, and TNF-<italic>&#x3b1;</italic> is associated with the development of CALs in KD patients (<xref ref-type="bibr" rid="B21">Hu et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B18">Guo et&#x20;al., 2020</xref>). The results indicated that the analysis results of this study are accurate. The etiology of KD is considered to have an infectious trigger in a genetically susceptible individual, followed by the activation of the immune system (<xref ref-type="bibr" rid="B48">Yim et&#x20;al., 2013</xref>). The main trigger pathogens suspected were the viral agents (<xref ref-type="bibr" rid="B43">Usta Guc et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B1">Alexoudi et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B9">Chang et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B40">Shulman et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B25">Kim et&#x20;al., 2016</xref>); some studies have linked triggers to bacteria agents (<xref ref-type="bibr" rid="B17">Galeotti et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B1">Alexoudi et&#x20;al., 2011</xref>). However, in our study, the levels of immune-related differentially expressed genes (DEGs) in bacterial infection samples were more similar to those of KD than viral infection samples. It is speculated that the bacteria triggering may be the main factor of the activation of the KD immune system.</p>
<p>Based on immune-related DEGs and machine learning algorithms, Lasso and SVM-RFE were performed to screen KD diagnostic markers. By integrating the features of the two algorithms, <italic>IL1B</italic>, <italic>ADM</italic>, <italic>PDGFC</italic>, and <italic>TGFA</italic> were selected as diagnostic biomarkers. Although the single biomarker for diagnosis and prognosis has been widely reported, value and robustness are also a major concern. So, we further developed a logistics prediction model with these 4 markers, and further external verification shows that the model was reliable. In our validation sets, two sets only contain acute KD and convalescent KD, but both diagnostic markers and model showed well differentiation. Interleukin-1<italic>&#x3b2;</italic> (IL-1<italic>&#x3b2;</italic>) is a potential inflammation-causing cytokine released predominantly by immune-derived cells. Studies indicate that IL-1<italic>&#x3b2;</italic> has a significant role in several aspects of vascular inflammation (<xref ref-type="bibr" rid="B8">Chamberlain et&#x20;al., 2006</xref>); there is a high level of IL-1<italic>&#x3b2;</italic> in the endothelium of atherosclerotic coronary arteries (<xref ref-type="bibr" rid="B10">Chibana et&#x20;al., 2017</xref>) and might be one of the targets of atherosclerotic protective therapy (<xref ref-type="bibr" rid="B37">Ridker et&#x20;al., 2017</xref>). Similarly, there are reports that the gene polymorphisms of IL-1<italic>&#x3b2;</italic> may be associated with initial IVIG treatment failure (<xref ref-type="bibr" rid="B44">Weng et&#x20;al., 2010</xref>) and significantly impact the risk of CAL formation in children with KD (<xref ref-type="bibr" rid="B16">Fu et&#x20;al., 2019</xref>). IL-1<italic>&#x3b2;</italic> may also increase the production of neutrophil extracellular traps by activating neutrophils, thereby inducing the progression of coronary artery ectasia (<xref ref-type="bibr" rid="B19">Guo et&#x20;al., 2020</xref>). Adrenomedullin (<italic>ADM</italic>) is a vasoactive peptide involved in vasodilation and regulation of endothelial function. ADM inhibits the apoptosis of cultured endothelial cells and the high permeability of human vascular smooth muscle cells induced by agonists (<xref ref-type="bibr" rid="B20">Hippenstiel et&#x20;al., 2002</xref>). Plasma ADM levels can reflect the degree of endothelial damage in atherosclerosis patients (<xref ref-type="bibr" rid="B7">Bunton et&#x20;al., 2004</xref>). It is a good indicator of prognosis in patients with coronary artery disease (<xref ref-type="bibr" rid="B45">Wong et&#x20;al., 2012</xref>). In KD, the expression level of <italic>ADM</italic> gene in plasma has been reported to be elevated (<xref ref-type="bibr" rid="B33">Nishida et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B34">Nomura et&#x20;al., 2005</xref>); plasma ADM levels were higher in KD patients developed CAAs than in those did not (Nishida K et&#x20;al., 2001). Platelet-derived growth factors (PDGFs) play an important role in vascular pathologies such as atherosclerosis, restenosis, and aortic aneurysm. PDGF-C can promote the migration and proliferation of macrophages (<xref ref-type="bibr" rid="B5">Boor et&#x20;al., 2010</xref>), endothelial cells (<xref ref-type="bibr" rid="B28">Li et&#x20;al., 2005</xref>), and vascular smooth muscle cells (<xref ref-type="bibr" rid="B13">Crawford et&#x20;al., 2009</xref>). <xref ref-type="bibr" rid="B24">Karvinen et&#x20;al. (2009)</xref> have revealed that PDGF-C is expressed in different stages of atherosclerosis. However, as a new member of the PDGF family, PDGF-C has been less studied in cardiovascular diseases since its discovery. However, <italic>PDGFC</italic> failed in GSE18606 when independently distinguishing KD from non-KD, which may be related to the small sample size of this dataset. Transforming growth factor <italic>&#x3b1;</italic> (TGF-<italic>&#x3b1;</italic>) as a member of the epidermal growth factor (EGF) family has been associated with cerebrovascular diseases (<xref ref-type="bibr" rid="B14">Dai et&#x20;al., 2020</xref>) and pulmonary vascular disease (<xref ref-type="bibr" rid="B27">Le Cras et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B6">Bouzina et&#x20;al., 2018</xref>). Similarly, TGF-<italic>&#x3b1;</italic> has been less studied in cardiovascular disease.</p>
<p>CIBERSORTx evaluation showed that the abundance of naive B&#x20;cells, activated memory CD4 T&#x20;cells, gamma delta T&#x20;cells, monocytes, M0 macrophages, activated dendritic cells, activated mast cells, and neutrophils was increased, and the abundance of memory B&#x20;cells, CD8 T&#x20;cells, activated memory CD4 T&#x20;cells, activated NK cells, M1 and M2 macrophages, and resting mast cells was decreased. Studies have shown that, CD8 T&#x20;cells, neutrophils, IgA plasma cells, and macrophages infiltrate and destroy the internal elastic lamina of medium-sized vessels (<xref ref-type="bibr" rid="B41">Takahashi et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B1">Alexoudi et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B35">Orenstein et&#x20;al., 2012</xref>). However, compared to CD8 T&#x20;cells, CD4 T&#x20;cells predominate in peripheral blood (<xref ref-type="bibr" rid="B1">Alexoudi et&#x20;al., 2011</xref>), which may be due to the CD8&#x20;T-cell transmission to tissues during the development of KD. In the acute phase of KD, the increase in the number of circulating neutrophils and activation eventually cause endothelial dysfunction (<xref ref-type="bibr" rid="B38">Sakurai et&#x20;al., 2019</xref>). In addition, our results revealed that CD8 T&#x20;cells are closely related to resting NK cells, macrophages M0, monocytes, activated dendritic cells, and neutrophils; regulatory T&#x20;cells (Tregs) are closely related to monocytes; resting NK cells are closely related to monocytes and activated dendritic cells; and activated dendritic cells are closely related to monocytes and resting mast cells. Considering the complexity of the immune system, it is difficult to study the immune cells of KD. Our analysis provides reference for the study of immune response in the pathogenesis of&#x20;KD.</p>
<p>We used novel scientific algorithms to identify the diagnostic markers for KD and verified them with multiple external datasets. CIBERSORTx was used to analyze the proportion of various immune cells in KD whole blood for the first time. Although the diagnostic model in this study is composed of only four genes with significant diagnostic impact, which makes it handy to use in clinical practice, it still has some limitations. Firstly, our research is the second mining and analysis of previously published datasets, and the sample size of two validation sets is small. Secondly, CIBERSORTx analysis is based on limited genetic data to infer cell-type abundance and cell-type-specific gene expression, which may deviate from the actual situation. In addition, the reliability of the results of our study needs further experiments to verify.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In the present study, 4&#x20;immune-related DEGs were identified, and a diagnostic model for KD was established and verified. The biological functions and pathways of the immune-related genes provide a detailed molecular mechanism for understanding the pathogenesis of KD. By CIBERSORTx algorithms, we found a difference in immune cells between KD and non-KD. These immune cells may play a key role in the pathogenesis and development of KD. Further analysis of the relation between immune-related DEGs and immune cells will be helpful to further explore the pathogenesis of KD and may determine the immunotherapy targets of KD (<xref ref-type="bibr" rid="B3">Bajolle et&#x20;al., 2014</xref>).</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>Publicly available datasets were analyzed in this study. These data can be found here: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gds/">https://www.ncbi.nlm.nih.gov/gds/</ext-link> (Gene Expression Omnibus) GSE73461, GSE68004, GSE18606, GSE73463, and GSE63881.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. Written informed consent from the participants&#x2019; legal guardian/next of kin was not required to participate in this study in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>DL, FJ, BL, and QY conceived and designed the study. DL performed the bioinformatics analyses. DL and FJ prepared figures and/or tables. DL and MXS authored drafts of the paper. MS organized the clinical and gene expression data. BL reviewed drafts of the paper. QY critically revised the drafts of the paper, and approved the final draft.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (Grant Number 81270412).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors thank the National Natural Science Foundation of China (No.81270412) for its support and GEO database for its generous sharing of&#x20;data.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexoudi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kanakis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kapsimali</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Vaiopoulos</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Kawasaki Disease: Current Aspects on Aetiopathogenesis and Therapeutic Management</article-title>. <source>Autoimmun. Rev.</source> <volume>10</volume>, <fpage>544</fpage>&#x2013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2011.04.005</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayusawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sonobe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Uemura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kiyosawa</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Revision of Diagnostic Guidelines for Kawasaki Disease (The 5th Revised Edition)</article-title>. <source>Pediatr. Int.</source> <volume>47</volume>, <fpage>232</fpage>&#x2013;<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1111/j.1442-200x.2005.02033.x</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajolle</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Meritet</surname>
<given-names>J.-F.</given-names>
</name>
<name>
<surname>Rozenberg</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chalumeau</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bonnet</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gendrel</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Markers of a Recent Bocavirus Infection in Children with Kawasaki Disease: "A Year Prospective Study"</article-title>. <source>Pathologie Biologie</source> <volume>62</volume>, <fpage>365</fpage>&#x2013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1016/j.patbio.2014.06.002</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Andorf</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pontius</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>ImmPort: Disseminating Data to the Public for the Future of Immunology</article-title>. <source>Immunol. Res.</source> <volume>58</volume>, <fpage>234</fpage>&#x2013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1007/s12026-014-8516-1</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boor</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>van Roeyen</surname>
<given-names>C. R. C.</given-names>
</name>
<name>
<surname>Kunter</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>B&#xfc;cher</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hohenstein</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>PDGF-C Mediates Glomerular Capillary Repair</article-title>. <source>Am. J.&#x20;Pathol.</source> <volume>177</volume>, <fpage>58</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2010.091008</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouzina</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>R&#xe5;degran</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Low Plasma Stem Cell Factor Combined with High Transforming Growth Factor-&#x3b1; Identifies High-Risk Patients in Pulmonary Arterial Hypertension</article-title>. <source>ERJ.&#x20;Open Res.</source> <volume>4</volume>, <fpage>00035</fpage>&#x2013;<lpage>02018</lpage>. <pub-id pub-id-type="doi">10.1183/23120541.00035-2018</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunton</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Petrie</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Hillier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>McMurray</surname>
<given-names>J.&#x20;J.&#x20;V.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>The Clinical Relevance of Adrenomedullin: a Promising Profile?</article-title> <source>Pharmacol. Ther.</source> <volume>103</volume>, <fpage>179</fpage>&#x2013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2004.07.002</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamberlain</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dewberry</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dower</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Crossman</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Interleukin-1&#x3b2; and Signaling of Interleukin-1 in Vascular Wall and Circulating Cells Modulates the Extent of Neointima Formation in Mice</article-title>. <source>Am. J.&#x20;Pathol.</source> <volume>168</volume>, <fpage>1396</fpage>&#x2013;<lpage>1403</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2006.051054</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>L.-Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>P.-L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>P.-I.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M.-T.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>T.-Y.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Viral Infections Associated with Kawasaki Disease</article-title>. <source>J.&#x20;Formos. Med. Assoc.</source> <volume>113</volume>, <fpage>148</fpage>&#x2013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/j.jfma.2013.12.008</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chibana</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kajimoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ueno</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>K.-i.</given-names>
</name>
<name>
<surname>Ohtsuka</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Interleukin-1&#x3b2; Is Associated with Coronary Endothelial Dysfunction in Patients with mTOR-Inhibitor-Eluting Stent Implantation</article-title>. <source>Heart Vessels</source> <volume>32</volume>, <fpage>823</fpage>&#x2013;<lpage>832</lpage>. <pub-id pub-id-type="doi">10.1007/s00380-017-0947-x</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.&#x20;N.</given-names>
</name>
<name>
<surname>Kil</surname>
<given-names>H. R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Cardiovascular Risk Factors of Early Atherosclerosis in School-Aged Children after Kawasaki Disease</article-title>. <source>Korean J.&#x20;Pediatr.</source> <volume>57</volume>, <fpage>217</fpage>&#x2013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.3345/kjp.2014.57.5.217</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>J.&#x20;T.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Adjuvant Laboratory Marker of Kawasaki Disease; NT-Pro-BNP or Hs-CRP?</article-title> <source>Ann. Clin. Lab. Sci.</source> <volume>41</volume>, <fpage>360</fpage>&#x2013;<lpage>363</lpage>. </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crawford</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kasman</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Modrusan</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment</article-title>. <source>Cancer Cell</source> <volume>15</volume>, <fpage>21</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2008.12.004</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>TGF&#x3b1; Preserves Oligodendrocyte Lineage Cells and Improves white Matter Integrity after Cerebral Ischemia</article-title>. <source>J.&#x20;Cereb. Blood Flow Metab.</source> <volume>40</volume>, <fpage>639</fpage>&#x2013;<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1177/0271678x19830791</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dionne</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meloche-Dumas</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Desjardins</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Turgeon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saint-Cyr</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Autmizguine</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>N-terminal Pro-B-type Natriuretic Peptide Diagnostic Algorithm versus American Heart Association Algorithm for Kawasaki Disease</article-title>. <source>Pediatr. Int.</source> <volume>59</volume>, <fpage>265</fpage>&#x2013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1111/ped.13154</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Q. L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>The IL-1B Gene Polymorphisms Rs16944 and Rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease</article-title>. <source>J.&#x20;Immunol. Res.</source> <volume>2019</volume>. <fpage>4730507</fpage> <pub-id pub-id-type="doi">10.1155/2019/4730507</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galeotti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bayry</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kone-Paut</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kaveri</surname>
<given-names>S. V.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Kawasaki Disease: Aetiopathogenesis and Therapeutic Utility of Intravenous Immunoglobulin</article-title>. <source>Autoimmun. Rev.</source> <volume>9</volume>, <fpage>441</fpage>&#x2013;<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2009.12.004</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Tumour Necrosis Factor&#x2010;&#x3b1; and Myoglobin Associated with the Recovery Time of Coronary Artery Lesions in Kawasaki Disease Patients</article-title>. <source>J.&#x20;Paediatr. Child. Health</source> <volume>56</volume>, <fpage>1382</fpage>&#x2013;<lpage>1387</lpage>. <pub-id pub-id-type="doi">10.1111/jpc.14942</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Neutrophil Activation and Neutrophil Derived Neutrophil Extracellular Trap Formation in Patients with Coronary Artery Ectasia</article-title>. <source>BMC Cardiovasc. Disord.</source> <volume>20</volume>, <fpage>101</fpage>. <pub-id pub-id-type="doi">10.1186/s12872-020-01398-0</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hippenstiel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Witzenrath</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schmeck</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hocke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Krisp</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kru&#x308;ll</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Adrenomedullin Reduces Endothelial Hyperpermeability</article-title>. <source>Circ. Res.</source> <volume>91</volume>, <fpage>618</fpage>&#x2013;<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.0000036603.61868.f9</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D. D.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>TNF-&#x3b1; Is superior to Conventional Inflammatory Mediators in Forecasting IVIG Nonresponse and Coronary Arteritis in Chinese Children with Kawasaki Disease</article-title>. <source>Clinica Chim. Acta</source> <volume>471</volume>, <fpage>76</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2017.05.019</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Jiang</surname>
</name>
</person-group> (<year>2014</year>). <article-title>BR, SVM-RFE Based Feature Selection and Taguchi Parameters Optimization for Multiclass SVM Classifier</article-title>, <source>ScientificWorldJournal</source>, <volume>2014</volume>. <fpage>795624</fpage>. <pub-id pub-id-type="doi">10.1155/2014/795624</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaggi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mejias</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moore-Clingenpeel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Whole Blood Transcriptional Profiles as a Prognostic Tool in Complete and Incomplete Kawasaki Disease</article-title>. <source>PLoS One</source> <volume>13</volume>. . <fpage>e0197858</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0197858</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karvinen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rutanen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lepp&#xe4;nen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Lach</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Levonen</surname>
<given-names>A.-L.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>U.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>PDGF-C and -D and Their Receptors PDGFR-&#x3b1; and PDGFR-&#x3b2; in Atherosclerotic Human Arteries</article-title>. <source>Eur. J.&#x20;Clin. Invest.</source> <volume>39</volume>, <fpage>320</fpage>&#x2013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2362.2009.02095.x</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D. S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Recent Advances in Kawasaki Disease</article-title>. <source>Yonsei. Med. J.</source> <volume>57</volume>, <fpage>15</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.3349/ymj.2016.57.1.15</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuo</surname>
<given-names>H.-C.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>K.-S.</given-names>
</name>
<name>
<surname>Ming-Huey Guo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>K.-P.</given-names>
</name>
<name>
<surname>Ger</surname>
<given-names>L.-P.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>W.-C.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Next-generation Sequencing Identifies Micro-RNA-based Biomarker Panel for Kawasaki Disease</article-title>. <source>J.&#x20;Allergy Clin. Immunol.</source> <volume>138</volume>, <fpage>1227</fpage>&#x2013;<lpage>1230</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.04.050</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Cras</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Hardie</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Fagan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Whitsett</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Korfhagen</surname>
<given-names>T. R.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Disrupted Pulmonary Vascular Development and Pulmonary Hypertension in Transgenic Mice Overexpressing Transforming Growth Factor-&#x3b1;</article-title>. <source>Am. J.&#x20;Physiology-Lung Cell Mol. Physiol.</source> <volume>285</volume>, <fpage>L1046</fpage>&#x2013;<lpage>L1054</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00045.2003</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tjwa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moons</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fons</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Noel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ny</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Revascularization of Ischemic Tissues by PDGF-CC via Effects on Endothelial Cells and Their Progenitors</article-title>. <source>J.&#x20;Clin. Invest.</source> <volume>115</volume>, <fpage>118</fpage>&#x2013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1172/jci19189</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>K.-H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.-S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C.-W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>H.-y.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Usefulness of Natriuretic Peptide for the Diagnosis of Kawasaki Disease: a Systematic Review and Meta-Analysis</article-title>. <source>BMJ&#x20;Open</source> <volume>5</volume>. <fpage>e006703</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2014-006703</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makino</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yashiro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ae</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tsuboi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aoyama</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Descriptive Epidemiology of Kawasaki Disease in Japan, 2011&#x2013;2012: From the Results of the 22nd Nationwide Survey</article-title>. <source>J.&#x20;Epidemiol.</source> <volume>25</volume>, <fpage>239</fpage>&#x2013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.2188/jea.je20140089</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCrindle</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Rowley</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Newburger</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Bolger</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Gewitz</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association</article-title>. <source>Circulation</source> <volume>135</volume>, <fpage>e927</fpage>&#x2013;<lpage>927e999</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000484</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newman</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Steen</surname>
<given-names>C. B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Gentles</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Chaudhuri</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Determining Cell Type Abundance and Expression from Bulk Tissues with Digital Cytometry</article-title>. <source>Nat. Biotechnol.</source> <volume>37</volume>, <fpage>773</fpage>&#x2013;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-019-0114-2</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishida</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Echigo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mayumi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishikimi</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Increased Plasma Adrenomedullin Levels in Kawasaki Disease with Coronary Artery Involvement</article-title>. <source>Am. J.&#x20;Med.</source> <volume>111</volume>, <fpage>165</fpage>&#x2013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1016/s0002-9343(01)00781-1</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nomura</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Noma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Adrenomedullin Is Highly Expressed in Blood Monocytes Associated with Acute Kawasaki Disease: a Microarray Gene Expression Study</article-title>. <source>Pediatr. Res.</source> <volume>57</volume>, <fpage>49</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1203/01.pdr.0000147745.52711.dd</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orenstein</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhatti</surname>
<given-names>T. R.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Three Linked Vasculopathic Processes Characterize Kawasaki Disease: a Light and Transmission Electron Microscopic Study</article-title>. <source>PLoS One</source> <volume>7</volume>. <fpage>e38998</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0038998</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rawat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rohit</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Pro-brain Natriuretic Peptide (ProBNP) Levels in North Indian Children with Kawasaki Disease</article-title>. <source>Rheumatol. Int.</source> <volume>36</volume>, <fpage>551</fpage>&#x2013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-016-3430-6</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ridker</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Everett</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Thuren</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>MacFadyen</surname>
<given-names>J.&#x20;G.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Ballantyne</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease</article-title>. <source>N. Engl. J.&#x20;Med.</source> <volume>377</volume>, <fpage>1119</fpage>&#x2013;<lpage>1131</lpage>. <pub-id pub-id-type="doi">10.1056/nejmoa1707914</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakurai</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Autoimmune Aspects of Kawasaki Disease</article-title>. <source>J.&#x20;Investig. Allergol. Clin. Immunol.</source> <volume>29</volume>, <fpage>251</fpage>&#x2013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.18176/jiaci.0300</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>S&#xe1;nchez-Manubens</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bou</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Anton</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Diagnosis and Classification of Kawasaki Disease</article-title>. <source>J.&#x20;Autoimmun.</source> <volume>48-49</volume>, <fpage>113</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2014.01.010</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shulman</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Rowley</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Kawasaki</surname>
<given-names>d.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Kawasaki Disease: Insights into Pathogenesis and Approaches to Treatment</article-title>. <source>Nat. Rev. Rheumatol.</source> <volume>11</volume>, <fpage>475</fpage>&#x2013;<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2015.54</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oharaseki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Naoe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wakayama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yokouchi</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Neutrophilic Involvement in the Damage to Coronary Arteries in Acute Stage of Kawasaki Disease</article-title>. <source>Pediatr. Int.</source> <volume>47</volume>, <fpage>305</fpage>&#x2013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1111/j.1442-200x.2005.02049.x</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tibshirani</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Regression Shrinkage and Selection via the Lasso</article-title>. <source>J.&#x20;R. Stat. Soc. Ser. B (Methodological)</source> <volume>58</volume>, <fpage>267</fpage>&#x2013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1111/j.2517-6161.1996.tb02080.x</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Usta Guc</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cengiz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yildirim</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Uslu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Cytomegalovirus Infection in a Patient with Atypical Kawasaki Disease</article-title>. <source>Rheumatol. Int.</source> <volume>28</volume>, <fpage>387</fpage>&#x2013;<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-007-0440-4</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weng</surname>
<given-names>K.-P.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>K.-S.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>T.-Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>C.-R.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>Y.-T.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>IL-1B Polymorphism in Association with Initial Intravenous Immunoglobulin Treatment Failure in Taiwanese Children with Kawasaki Disease</article-title>. <source>Circ. J.</source> <volume>74</volume>, <fpage>544</fpage>&#x2013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1253/circj.cj-09-0664</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>T. T.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>B. M. Y.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Adrenomedullin and Cardiovascular Diseases</article-title>. <source>JRSM Cardiovasc. Dis.</source> <volume>1</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1258/cvd.2012.012003</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname>
<given-names>V. J.</given-names>
</name>
<name>
<surname>Herberg</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Kaforou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Eleftherohorinou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shailes</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature</article-title>. <source>JAMA Pediatr.</source> <volume>172</volume>. <fpage>e182293</fpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2018.2293</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-Analysis of Genetic Association Studies</article-title>. <source>Pediatr. Cardiol.</source> <volume>39</volume>, <fpage>207</fpage>&#x2013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1007/s00246-017-1760-0</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Burgner</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Update on Kawasaki Disease: Epidemiology, Aetiology and Pathogenesis</article-title>. <source>J.&#x20;Paediatr. Child. Health</source> <volume>49</volume>, <fpage>704</fpage>&#x2013;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1111/jpc.12172</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.-G.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q.-Y.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters</article-title>. <source>OMICS: A J.&#x20;Integr. Biol.</source> <volume>16</volume>, <fpage>284</fpage>&#x2013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M.-G.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>L.-J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>T.-T.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Meta-analysis of Risk Factors Associated with Atherosclerosis in Patients with Kawasaki Disease</article-title>. <source>World J.&#x20;Pediatr.</source> <volume>12</volume>, <fpage>308</fpage>&#x2013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1007/s12519-016-0023-0</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>